These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations. Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504 [TBL] [Abstract][Full Text] [Related]
4. There is reduced immunohistochemical staining of placental aromatase in severe neonatal opioid withdrawal syndrome. Townsel C; Odukoya E; Rae J; Thomas D J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9227-9233. PubMed ID: 34978244 [TBL] [Abstract][Full Text] [Related]
8. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression. Baldo BA Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419 [TBL] [Abstract][Full Text] [Related]
9. Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizons. Radhakrishna U; Sadhasivam S; Radhakrishnan R; Forray A; Muvvala SB; Metpally RP; Patel S; Rawal RM; Vishweswaraiah S; Bahado-Singh RO; Nath SK Front Genet; 2023; 14():1292148. PubMed ID: 38264209 [No Abstract] [Full Text] [Related]
10. Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome. Radhakrishna U; Nath SK; Uppala LV; Veerappa A; Forray A; Muvvala SB; Metpally RP; Crist RC; Berrettini WH; Mausi LM; Vishweswaraiah S; Bahado-Singh RO Front Genet; 2023; 14():1215472. PubMed ID: 37434949 [No Abstract] [Full Text] [Related]
11. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone. Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398 [TBL] [Abstract][Full Text] [Related]
12. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome? Gersch H; Shah D; Chroust A; Bailey B J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045 [TBL] [Abstract][Full Text] [Related]
13. Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome. Chavan NR; Ashford KB; Wiggins AT; Lofwall MR; Critchfield AS AJP Rep; 2017 Oct; 7(4):e215-e222. PubMed ID: 29226017 [No Abstract] [Full Text] [Related]
14. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning. Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns. Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312 [TBL] [Abstract][Full Text] [Related]
16. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches. McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111 [TBL] [Abstract][Full Text] [Related]
17. Associations between in utero exposure to polybrominated diphenyl ethers, pathophysiological state of fetal growth and placental DNA methylation changes. Zhao Y; Song Q; Ge W; Jin Y; Chen S; Zhao Y; Xiao X; Zhang Y Environ Int; 2019 Dec; 133(Pt B):105255. PubMed ID: 31655276 [TBL] [Abstract][Full Text] [Related]
18. Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure. Pourcyrous M; Elabiad MT; Rana D; Gaston KP; DeBaer L; Dhanireddy R Pediatr Res; 2021 Aug; 90(2):459-463. PubMed ID: 33214673 [TBL] [Abstract][Full Text] [Related]
19. In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome. Griffin BA; Caperton CO; Russell LN; Cabanlong CV; Wilson CD; Urquhart KR; Martins BS; Zita MD; Patton AL; Alund AW; Owens SM; Fantegrossi WE; Moran JH; Brents LK J Pharmacol Exp Ther; 2019 Jul; 370(1):9-17. PubMed ID: 31028107 [TBL] [Abstract][Full Text] [Related]
20. Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan. Goshgarian G; Jawad R; O'Brien L; Muterspaugh R; Zikos D; Ezhuthachan S; Newman C; Hsu CD; Bailey B; Ragina N Cureus; 2022 Aug; 14(8):e27790. PubMed ID: 36106254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]